pInducer20 Cyclin E1 Citations (2)

Originally described in: Rapid DNA replication origin licensing protects stem cell pluripotency.
Matson JP, Dumitru R, Coryell P, Baxley RM, Chen W, Twaroski K, Webber BR, Tolar J, Bielinsky AK, Purvis JE, Cook JG Elife. 2017 Nov 17;6. doi: 10.7554/eLife.30473. PubMed Journal

---

Articles Citing pInducer20 Cyclin E1

Articles
A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC. Goto Y, Koshizuka K, Ando T, Izumi H, Wu X, Sato K, Ishikawa T, Ford K, Feng X, Wang Z, Arang N, Allevato MM, Kishore A, Mali P, Gutkind JS. Cancer Res Commun. 2024 Jul 1;4(7):1850-1862. doi: 10.1158/2767-9764.CRC-24-0247. PubMed
Oncogenic YAP sensitizes cells to CHK1 inhibition via CDK4/6 driven G1 acceleration. Gertzmann D, Presek C, Mattes AL, Sanger M, Zoller M, Schulein-Volk C, Ade CP, Eilers M, Gaubatz S. EMBO Rep. 2025 Aug;26(16):4017-4039. doi: 10.1038/s44319-025-00514-5. Epub 2025 Jul 4. PubMed

If you have published an article using this material, please email us at to have your article added to this page.